VDJ-020

N/A

Report date: 2025/06/09 17:26:45

Base Information

Drug NameVDJ-020
Drug Alias NameVDJ020VDJ-020
ClassificationBiologics
Mechanisms of ActionInterleukin-6 receptor subunit beta modulators
TargetsInterleukin-6 receptor subunit beta
Therapy Area/IndicationsAtherosclerosisRenal Insufficiency, ChronicGraves Ophthalmopathy +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Vdjbio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Vdjbio Co Ltd
Inactive CompaniesN/A
Active IndicationsAtherosclerosisRenal Insufficiency, ChronicGraves Ophthalmopathy +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A